A study in patients with ARDS or at risk for ARDS examined specific BALF IL-1 biological activity by measuring IL-1β effect on A549 cell adhesion molecule response (an IL-1 biological action) in samples collected over 21 days (Park et al., 2001). This evidence concerns the gene IL1A and acute respiratory distress syndrome.